On the recordSeptember 20, 2016
The bottom line is you took a very inexpensive drug and you profited handsomely off it.
Source
congress.govEditor's note · Context
DesJarlais criticizes the high pricing of EpiPens despite their low cost.
Share & report
More from Scott DesJarlais
Feb 1, 2022
The last thing they need, and so many others in agriculture, is more regulations.
May 16, 2017
Can folks in Tennessee count on you to be supportive of the Walking Horse industry, and facilitate scientific and objective inspection methods to eliminate soring?
Jun 6, 2023
I firmly believe SNAP was intended to temporarily serve American families, giving them the leg up they need to be self-sufficient.
May 19, 2019
What will USDA's involvement be in both this case and in preventing the spread of EP in the United States?
Other voices in this conversation
